Safety and efficacy of VMAT2 inhibitors in Huntington Disease: A systematic review

Key Points

• Safety and efficacy evaluations reveal positive outcomes with VMAT2 inhibitors in Huntington Disease.
• The systematic review incorporates various studies, highlighting efficacy metrics and safety profiles.
• Observational analysis across multiple clinical contexts provides insights on VMAT2 inhibitors' impact on disease symptoms.
• Supports the need for further investigation of VMAT2 inhibitors to enhance treatment options for Huntington Disease.